{
  "abstract": "A 34-year-old man with multisystem sarcoidosis developed worsening breathlessness, cough, chest pain, palpitations, bone and joint pain, a progressive skin rash and 18 kg weight loss over 2 years. He was diagnosed 3 years earlier with granulomatous uveitis and mediastinal lymphadenopathy, with endobronchial ultrasound-guided biopsy confirming non-necrotising granulomatous inflammation. He was treated with high-dose corticosteroids and methotrexate, and later switched to adalimumab due to steroid toxicity and abnormal liver function. Adalimumab was prescribed at a standard dose of 40 mg every 2 weeks and continued for 2.5 years. Despite this therapy, his disease progressed.",
  "authors": [
    {
      "affiliations": [
        "Department of Inflammation Biology, King’s College London, London, UK",
        "Rheumatology, King's College Hospital, London, UK"
      ],
      "name": "Kathryn Biddle"
    },
    {
      "affiliations": [
        "Guy’s and St Thomas’ PET Centre, London, UK",
        "Department of Cancer Imaging, King’s College London, London, UK"
      ],
      "name": "Manil Subesinghe"
    },
    {
      "affiliations": [
        "Department of Inflammation Biology, King’s College London, London, UK",
        "Rheumatology, King's College Hospital, London, UK"
      ],
      "name": "Katie Bechman"
    },
    {
      "affiliations": [
        "Respiratory Medicine, Guy’s and St Thomas’ Hospitals NHS Trust, London, UK"
      ],
      "name": "Anne Collett"
    },
    {
      "affiliations": [
        "Department of Inflammation Biology, King’s College London, London, UK",
        "Rheumatology, King's College Hospital, London, UK"
      ],
      "name": "James Galloway"
    }
  ],
  "title": "Refractory multisystem sarcoidosis on a long axial field of view (LAFOV) PET-CT system",
  "uid": "98baa97b-9586-52a3-9180-4e2144b508f3"
}